IDXX

Q: What is the price of IDEXX Laboratories (IDXX) today?

The price of IDEXX Laboratories (IDXX) today is US$ 616,15, with a variation of 30.19% compared to the last year. The price of IDEXX Laboratories (IDXX) started the year trading around US$ 413,44 and today it is at US$ 616,15. Follow the real-time price chart, the historical price of IDEXX Laboratories (IDXX), and stock data from Ibovespa and international markets.

Q: When does IDEXX Laboratories (IDXX) pay dividends?

IDEXX Laboratories (IDXX) did not distribute dividends in the last year.

Q: IDEXX Laboratories (IDXX) is it worth it?

Currently, IDEXX Laboratories (IDXX) is priced at US$ 616,15, with a P/E of 48,24%, representing a deviation of 53,60% from its historical average P/E. In the last year, the stock showed a variation of 30.19% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 30,19%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of IDEXX Laboratories (IDXX)?

Investing in stocks of IDEXX Laboratories (IDXX) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of IDEXX Laboratories (IDXX) yield today?

The yield of IDEXX Laboratories (IDXX) was -3,42% in the last month, 30,19% in the last year and 46,92% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of IDEXX Laboratories (IDXX) today, the total investment would be US$ 61.615,00, based on the current price of US$ 616,15.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 80.216,57In 5 years: US$ 90.524,76In 10 years: 530.449,70It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

IDEXX Laboratories Inc.

Price

US$ 616,15

variation (12m)

30,19%

p/l

48,24

p/vp

34,61

DIVIDEND YIELD

0,00%

price IDXX

BVMF

IDXX

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of IDXX

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-3,42%

3 months

15,52%

1 year

30,19%

2 years

43,86%

5 years

46,92%

10 years

760,91%

real profitability

profitability minus inflation.

1 month

-3,42%

3 months

15,09%

1 year

24,48%

2 years

31,30%

5 years

8,57%

10 years

415,44%

Indicators IDXX

check out the fundamentals of IDEXX Laboratories shares

P/E

48,24

Sector: -1,19 Industry: -3,13

P/SALES RATIO (PSR)

12,10

Sector: 1,95 Industry: 2,78

P/BV

34,61

Sector: 2,22 Industry: 1,88

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

31,43%

Sector: -26,82% Industry: -52,06%

ROE

71,76%

Sector: -29,98% Industry: -40,51%

ROIC

44,76%

Sector: -411,56% Industry: -412,66%

NET MARGIN

25,09%

Sector: -27,32% Industry: -30,04%

GROSS MARGIN

61,93%

Sector: 43,14% Industry: 44,05%

OPERATING MARGIN

31,75%

Sector: -23,36% Industry: -26,70%

P/EBITDA

35,25

Sector: 0,02 Industry: -2,09

P/EBIT

38,06

Sector: -1,26 Industry: -2,90

P/ASSET

15,16

Sector: 1,27 Industry: 1,41

BVPS

18,24

Sector: 3,73 Industry: 1,64

EPS

13,09

Sector: -0,77 Industry: -1,17

EQUITY / ASSETS

0,44

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

8,28%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

11,18%

Sector: - Industry: -

FAIR PRICE OF IDEXX Laboratories ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 616,15

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-88,10%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

IDXX indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,65	41,10	75,21%	0,69%	US$ 754,20 B	25,91%
ISRG	60,13	9,05	15,04%	0,00%	US$ 162,39 B	28,29%
TMO	31,25	4,06	12,99%	0,30%	US$ 205,37 B	15,12%
SNY	7,88	1,54	19,52%	4,35%	US$ 124,76 B	22,40%
MDT	26,88	2,60	9,68%	2,88%	US$ 125,25 B	13,63%
CVS	17,95	1,27	7,05%	3,43%	US$ 98,10 B	1,40%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
NVS	17,78	6,13	34,49%	2,92%	US$ 257,90 B	25,52%
GSK	13,33	4,47	33,57%	3,74%	US$ 87,13 B	15,70%
BSX	50,82	6,36	12,51%	0,00%	US$ 144,03 B	14,65%
TMDX	38,43	12,37	32,18%	0,00%	US$ 3,93 B	17,65%
HCA	16,16	-82,92	-513,25%	0,66%	US$ 102,66 B	8,61%
DHR	48,94	2,95	6,02%	0,55%	US$ 154,15 B	13,04%
INMD	6,18	1,52	24,58%	0,00%	US$ 954,45 M	42,09%
FMS	20,85	0,95	4,56%	2,94%	US$ 15,70 B	3,48%
PHG	92,60	2,21	2,38%	3,16%	US$ 26,49 B	1,45%
HUM	20,85	1,87	8,97%	1,25%	US$ 34,21 B	1,30%
RMD	27,69	6,82	24,62%	0,79%	US$ 40,67 B	27,88%
CNC	17,57	0,70	3,96%	0,00%	US$ 19,12 B	0,59%

comparison of IDXX with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History IDXX

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY IDEXX Laboratories

IDEXX Laboratories Inc.

Average user rating I10

4.0 (20 people)

Estados Unidos

42 years

Foundation: 1983

1991

Year of debut on the stock exchange - 34 years

10.350

Employees

The Company IDEXX Laboratories Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 50,50 Billions, having a net worth of $ 1,46 Billion.

With a total of 10.350 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 4,17 Billions, which generated a profit in the amount of $ 1,05 Billion.

As for its main indicators, the Company has a P/E ratio of 48,24, a P/BV ratio of 34,61 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker IDXX.

Market value

US$ 50,50 Billions

Net worth

US$ 1,46 Billion

US$ 1.458.830.000,00

Assets

US$ 3,33 Billions

US$ 3.330.790.000,00

Total Number of Shares

80,00 Milhões

80.000.000

Average Daily Trading Volume

US$ 580,63 Thousand

US$ 580.630,00

Sector

Health

Industry

Medical Supplies and Equipment

IDXX

IDXX revenue and profits

IDXX results

DRAG THE FRAME TO SEE MORE DATA

IDXX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12 M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12 M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12 M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12 M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12 M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12 M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12 M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

Frequently Asked Questions

What is the price of IDEXX Laboratories (IDXX) today?

The price of IDEXX Laboratories (IDXX) today is US$ 616,15, with a variation of 30.19% compared to the last year. The price of IDEXX Laboratories (IDXX) started the year trading around US$ 413,44 and today it is at US$ 616,15. Follow the real-time price chart, the historical price of IDEXX Laboratories (IDXX), and stock data from Ibovespa and international markets.

When does IDEXX Laboratories (IDXX) pay dividends?

IDEXX Laboratories (IDXX) did not distribute dividends in the last year.

IDEXX Laboratories (IDXX) is it worth it?

Currently, IDEXX Laboratories (IDXX) is priced at US$ 616,15, with a P/E of 48,24%, representing a deviation of 53,60% from its historical average P/E. In the last year, the stock showed a variation of 30.19% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 30,19%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of IDEXX Laboratories (IDXX)?

Investing in stocks of IDEXX Laboratories (IDXX) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of IDEXX Laboratories (IDXX) yield today?

The yield of IDEXX Laboratories (IDXX) was -3,42% in the last month, 30,19% in the last year and 46,92% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of IDEXX Laboratories (IDXX) today, the total investment would be US$ 61.615,00, based on the current price of US$ 616,15.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 80.216,57
In 5 years: US$ 90.524,76
In 10 years: 530.449,70

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

IDXX

IDEXX Laboratories Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of IDXX

check out the fundamentals of IDEXX Laboratories shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY IDEXX Laboratories

IDEXX Laboratories Inc.

Estados Unidos

42 years

1991

10.350

PROFIT X PRICE IDXX

IDXX results

IDXX cash flow

evolution of assets - IDXX

IDXX balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions